Nexalin Technology Inc./$NXL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the US and China, with China generating the maximum sales.
Ticker
$NXL
Sector
Primary listing
Employees
8
Headquarters
Website
NXL Metrics
BasicAdvanced
$7.3m
-
-$0.46
4.03
-
Price and volume
Market cap
$7.3m
Beta
4.03
52-week high
$2.00
52-week low
$0.31
Average daily volume
254k
Financial strength
Current ratio
4.07
Quick ratio
3.404
Profitability
EBITDA (TTM)
-8.472
Gross margin (TTM)
81.99%
Net profit margin (TTM)
-3,022.94%
Operating margin (TTM)
-3,084.03%
Revenue per employee (TTM)
$30,000
Management effectiveness
Return on assets (TTM)
-161.10%
Return on equity (TTM)
-319.69%
Valuation
Price to revenue (TTM)
22.09
Price to book
2.41
Price to tangible book (TTM)
2.75
Price to free cash flow (TTM)
-1.128
Free cash flow yield (TTM)
-88.66%
Free cash flow per share (TTM)
-0.299
Growth
Revenue change (TTM)
110.26%
Earnings per share change (TTM)
-42.27%
3-year revenue growth (CAGR)
-35.53%
3-year earnings per share growth (CAGR)
11.60%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.